NEW YORK – Leica Biosystems and Sectra announced on Monday a collaboration to develop an integrated clinical pathology solution with an eventual intended submission to the US Food and Drug Administration for 510(k) clearance.
NEW YORK – Leica Biosystems and Sectra announced on Monday a collaboration to develop an integrated clinical pathology solution with an eventual intended submission to the US Food and Drug Administration for 510(k) clearance.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.